Home  »  Stock   »  Palisade Bio Inc. (PALI): Is this the Most Sought-...

Palisade Bio Inc. (PALI): Is this the Most Sought-After Stock Today?

Let’s start up with the current stock price of Palisade Bio Inc. (PALI), which is $4.69 to be very precise. The Stock rose vividly during the last session to $2.61 after opening rate of $2.45 while the lowest price it went was recorded $2.04 before closing at $2.21.

Palisade Bio Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $81.00 on 02/02/22, with the lowest value was $2.04 for the same time period, recorded on 11/21/22.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report


Palisade Bio Inc. (PALI) full year performance was -98.20%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Palisade Bio Inc. shares are logging -96.50% during the 52-week period from high price, and 129.90% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.04 and $134.00.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 31953553 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Palisade Bio Inc. (PALI) recorded performance in the market was -96.60%, having the revenues showcasing -73.63% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 184.91M, as it employees total of 13 workers.

The Analysts eye on Palisade Bio Inc. (PALI)

During the last month, 0 analysts gave the Palisade Bio Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 10.48, with a change in the price was noted -15.58. In a similar fashion, Palisade Bio Inc. posted a movement of -78.10% for the period of last 100 days, recording 420,656 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for PALI is recording 0.14 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Technical rundown of Palisade Bio Inc. (PALI)

Raw Stochastic average of Palisade Bio Inc. in the period of last 50 days is set at 33.00%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 47.03%. In the last 20 days, the company’s Stochastic %K was 17.19% and its Stochastic %D was recorded 8.10%.

Considering, the past performance of Palisade Bio Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -96.60%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -91.66%, alongside a downfall of -98.20% for the period of the last 12 months. The shares increased approximately by -46.03% in the 7-day charts and went up by -57.50% in the period of the last 30 days. Common stock shares were lifted by -73.63% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts